William G. Honer
#138,940
Most Influential Person Now
Researcher
William G. Honer's AcademicInfluence.com Rankings
William G. Honerengineering Degrees
Engineering
#5108
World Rank
#6348
Historical Rank
Electrical Engineering
#1377
World Rank
#1468
Historical Rank
William G. Honercomputer-science Degrees
Computer Science
#6552
World Rank
#6908
Historical Rank
Computational Linguistics
#1159
World Rank
#1173
Historical Rank
Machine Learning
#2169
World Rank
#2197
Historical Rank
Artificial Intelligence
#2432
World Rank
#2473
Historical Rank
Download Badge
Engineering Computer Science
William G. Honer's Degrees
- PhD Computer Science Stanford University
- Masters Electrical Engineering University of California, Berkeley
Similar Degrees You Can Earn
Why Is William G. Honer Influential?
(Suggest an Edit or Addition)William G. Honer's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology. (2017) (567)
- Hippocampal plasticity in response to exercise in schizophrenia. (2010) (544)
- Location of a major susceptibility locus for familial schizophrenia on chromosome 1q21-q22. (2000) (520)
- Correlations of synaptic and pathological markers with cognition of the elderly (1995) (436)
- The need for speed: an update on methamphetamine addiction. (2006) (419)
- Abnormal accumulation of NACP/alpha-synuclein in neurodegenerative disorders. (1998) (410)
- Abnormalities of myelination in schizophrenia detected in vivo with MRI, and post-mortem with analysis of oligodendrocyte proteins (2003) (404)
- Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer's disease (1994) (402)
- Methamphetamine use: a comprehensive review of molecular, preclinical and clinical findings. (2013) (345)
- Human Hippocampal Neurogenesis Persists in Aged Adults and Alzheimer's Disease Patients. (2019) (296)
- Much of late life cognitive decline is not due to common neurodegenerative pathologies (2013) (268)
- Linkage of familial schizophrenia to chromosome 13q32. (1999) (214)
- Synaptic and plasticity-associated proteins in anterior frontal cortex in severe mental illness (1999) (203)
- SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer’s disease (2014) (202)
- Staging of cytoskeletal and beta-amyloid changes in human isocortex reveals biphasic synaptic protein response during progression of Alzheimer's disease. (2000) (200)
- SNAP-25 deficit and hippocampal connectivity in schizophrenia. (1998) (186)
- Clozapine alone versus clozapine and risperidone with refractory schizophrenia. (2006) (183)
- Evidence for anticipation in schizophrenia. (1994) (180)
- DNA copy-number analysis in bipolar disorder and schizophrenia reveals aberrations in genes involved in glutamate signaling. (2006) (173)
- Guidelines for the Pharmacotherapy of Schizophrenia in Adults (2017) (172)
- Regional synaptic pathology in Alzheimer's disease (1992) (170)
- Relations between Brain Pathology and Temporal Lobe Epilepsy (2002) (165)
- Cingulate cortex synaptic terminal proteins and neural cell adhesion molecule in schizophrenia (1997) (156)
- Temporal lobe involvement in multiple sclerosis patients with psychiatric disorders. (1987) (153)
- Abnormalities of SNARE mechanism proteins in anterior frontal cortex in severe mental illness. (2002) (150)
- Disturbed gyrification of the prefrontal region in male schizophrenic patients: A morphometric postmortem study. (2000) (144)
- Neurocognitive functioning in patients with bipolar I disorder recently recovered from a first manic episode. (2010) (142)
- Maintenance treatment with quetiapine versus discontinuation after one year of treatment in patients with remitted first episode psychosis: randomised controlled trial (2010) (138)
- Pathology of presynaptic proteins in Alzheimer’s disease: more than simple loss of terminals (2003) (136)
- Increased concentrations of presynaptic proteins in the cingulate cortex of subjects with schizophrenia. (1997) (132)
- Cardiovascular side-effects of antipsychotic drugs: the role of the autonomic nervous system. (2012) (129)
- Persistent antipsychotic polypharmacy and excessive dosing in the community psychiatric treatment setting: a review of medication profiles in 435 Canadian outpatients. (2010) (124)
- An MRI study of basal ganglia volumes in first-episode schizophrenia patients treated with risperidone. (2001) (119)
- Entorhinal cortex pre-alpha cell clusters in schizophrenia: quantitative evidence of a developmental abnormality (2000) (118)
- Atrophy of superior cerebellar peduncle in progressive supranuclear palsy (2003) (116)
- Hippocampal complexin proteins and cognitive dysfunction in schizophrenia. (2005) (115)
- Left Prefrontal High-Frequency Repetitive Transcranial Magnetic Stimulation for the Treatment of Schizophrenia with Predominant Negative Symptoms: A Sham-Controlled, Randomized Multicenter Trial (2015) (115)
- Olfactory hallucinations and olfactory identification ability in patients with schizophrenia and other psychiatric disorders (1994) (113)
- Extrapyramidal signs and clinical symptoms in first-episode schizophrenia: response to low-dose risperidone. (1997) (111)
- Right frontal hypergyria differentiation in affected and unaffected siblings from families multiply affected with schizophrenia: a morphometric mri study. (2001) (108)
- Reductions in cholesterol and synaptic markers in association cortex in mood disorders. (2005) (107)
- Preclinical models of antipsychotic drug-induced metabolic side effects. (2010) (106)
- The SNAP-25 gene may be associated with clinical response and weight gain in antipsychotic treatment of schizophrenia (2005) (101)
- Synapse alterations in the hippocampal-entorhinal formation in Alzheimer's disease with and without Lewy body disease (1994) (96)
- Altered immunoreactivity of complexin protein in prefrontal cortex in severe mental illness (2002) (94)
- Changes in serum lipids, independent of weight, are associated with changes in symptoms during long-term clozapine treatment. (2007) (93)
- Cognitive reserve, presynaptic proteins and dementia in the elderly (2012) (91)
- The hotel study: multimorbidity in a community sample living in marginal housing. (2013) (89)
- Reduced basal ganglia volumes after switching to olanzapine in chronically treated patients with schizophrenia. (2004) (89)
- Impaired olfactory identification in relatives of patients with familial schizophrenia. (2001) (86)
- Reproductive fitness in familial schizophrenia (1995) (86)
- Self-reported motivation to smoke in schizophrenia is related to antipsychotic drug treatment (2008) (85)
- Impaired Efficiency of Functional Networks Underlying Episodic Memory-for-Context in Schizophrenia (2010) (83)
- Loss of synaptic but not cytoskeletal proteins in the cerebellum of chronic schizophrenics (2002) (83)
- Relationship between cognitive functioning and 6-month clinical and functional outcome in patients with first manic episode bipolar I disorder (2010) (83)
- Presynaptic Trafficking of Synaptotagmin I Is Regulated by Protein Palmitoylation* (2004) (83)
- Identification of genes associated with dissociation of cognitive performance and neuropathological burden: Multistep analysis of genetic, epigenetic, and transcriptional data (2017) (79)
- Aerobic exercise and yoga improve neurocognitive function in women with early psychosis (2015) (79)
- Synaptic Pathology in Prefrontal Cortex is Present Only with Severe Dementia in Alzheimer Disease (2001) (78)
- Cholinergic fibre loss associated with diffuse plaques in the non-demented elderly: the preclinical stage of Alzheimer’s disease? (1997) (77)
- Risperidone, serotonergic mechanisms, and obsessive-compulsive symptoms in schizophrenia. (1994) (75)
- Effects of Endurance Training Combined With Cognitive Remediation on Everyday Functioning, Symptoms, and Cognition in Multiepisode Schizophrenia Patients. (2015) (75)
- Consensus statement on the use of clozapine during the COVID-19 pandemic (2020) (75)
- Decreased frontal lobe ratio of N-acetyl aspartate to choline in familial schizophrenia: a proton magnetic resonance spectroscopy study (2000) (74)
- Kraepelin revisited: schizophrenia from degeneration to failed regeneration (2015) (73)
- Long-term effects of discontinuation from antipsychotic maintenance following first-episode schizophrenia and related disorders: a 10 year follow-up of a randomised, double-blind trial. (2018) (73)
- Human synaptic proteins with a heterogeneous distribution in cerebellum and visual cortex (1993) (71)
- Three‐year outcome of phase‐specific early intervention for first‐episode psychosis: a cohort study in Hong Kong (2011) (70)
- An open trial of risperidone augmentation of partial response to clozapine (2001) (69)
- Disturbed frontal gyrification within families affected with schizophrenia. (2007) (68)
- Cognitive Effects of High-Frequency rTMS in Schizophrenia Patients With Predominant Negative Symptoms: Results From a Multicenter Randomized Sham-Controlled Trial. (2016) (67)
- Scopolamine Reduces Frontal Cortex Perfusion (1988) (67)
- Use of a quantitative trait to map a locus associated with severity of positive symptoms in familial schizophrenia to chromosome 6p. (1997) (66)
- The Association of Elevated Body Mass Index with Reduced Brain Volumes in First-Episode Mania (2011) (65)
- No evidence for linkage of the CHRNA7 gene region in Canadian schizophrenia families. (1998) (64)
- Heterozygous reeler mice exhibit alterations in sensorimotor gating but not presynaptic proteins (2008) (63)
- Brain tocopherols related to Alzheimer's disease neuropathology in humans (2015) (63)
- The impact of atypical antipsychotic medications on long-term memory dysfunction in schizophrenia spectrum disorder: a quantitative review (2006) (62)
- The genomic era and perceptions of psychotic disorders: Genetic risk estimation, associations with reproductive decisions and views about predictive testing (2006) (62)
- Ethyl-EPA treatment improves motor dysfunction, but not neurodegeneration in the YAC128 mouse model of Huntington disease (2005) (62)
- Effects of endurance training on brain structures in chronic schizophrenia patients and healthy controls (2016) (62)
- Symptoms in neuroleptic-naive, first-episode schizophrenia: response to risperidone (1996) (62)
- Differential effects of 3 classes of antidiabetic drugs on olanzapine-induced glucose dysregulation and insulin resistance in female rats. (2012) (61)
- Extrapyramidal symptoms and signs in first-episode, antipsychotic exposed and non-exposed patients with schizophrenia or related psychotic illness (2005) (60)
- Traumatic brain injury in homeless and marginally housed individuals: a systematic review and meta-analysis. (2019) (59)
- The effect of aerobic exercise on cortical architecture in patients with chronic schizophrenia: a randomized controlled MRI study (2013) (58)
- Results of Computerised Tomography During First Admission for Psychosis (1994) (58)
- Abnormalities of presynaptic protein CDCrel‐1 in striatum of rats reared in social isolation: relevance to neural connectivity in schizophrenia (2004) (58)
- Positive and negative symptoms in families with schizophrenia (1993) (56)
- A Novel Mechanism and Treatment Target for Presynaptic Abnormalities in Specific Striatal Regions in Schizophrenia (2010) (55)
- Body Mass Index–Related Regional Gray and White Matter Volume Reductions in First-Episode Mania Patients (2014) (55)
- Olfactory function in monozygotic twins discordant for schizophrenia. (1998) (55)
- Psychiatric genetic counselling for parents of individuals affected with psychotic disorders: a pilot study (2008) (55)
- The incidence of schizophrenia in European immigrants to Canada (2006) (54)
- Predicting Response to Repetitive Transcranial Magnetic Stimulation in Patients With Schizophrenia Using Structural Magnetic Resonance Imaging: A Multisite Machine Learning Analysis (2018) (54)
- The assessment of symptom severity and functional impairment with DSM-IV axis V. (2011) (54)
- Reduced anterior internal capsule and thalamic volumes in first-episode psychosis (2006) (54)
- Olfactory identification ability in pre- and postmenopausal women with schizophrenia (1995) (54)
- Predictors of Persistent Psychotic Symptoms in Persons With Methamphetamine Abuse Receiving Psychiatric Treatment (2013) (52)
- 12‐month longitudinal cognitive functioning in patients recently diagnosed with bipolar disorder (2014) (51)
- Localization of a novel septin protein, hCDCrel‐1, in neurons of human brain (1998) (51)
- Dementia as a complication of schizophrenia (2001) (51)
- Organization of the secretory machinery in the rodent brain: distribution of the t-SNAREs, SNAP-25 and SNAP-23 (1999) (51)
- Metabolic abnormalities in fronto-striatal-thalamic white matter tracts in schizophrenia (2009) (50)
- Developmental abnormalities of the hippocampus in First-Episode schizophrenia (2003) (50)
- Effects of eight weeks of atypical antipsychotic treatment on middle frontal thickness in drug-naïve first-episode psychosis patients (2013) (50)
- An open comparison of clozapine and risperidone in treatment-resistant schizophrenia. (1998) (50)
- A pilot randomized clinical trial evaluating the impact of genetic counseling for serious mental illnesses. (2016) (50)
- Cortical Cholinergic Denervation Elicits Vascular Aβ Deposition (2000) (49)
- Violence in Treatment Resistant Psychotic Inpatients (2001) (49)
- Intermittent treatment with olanzapine causes sensitization of the metabolic side-effects in rats (2012) (49)
- Antipsychotic and Psychostimulant Drug Combination Therapy in Attention Deficit/Hyperactivity and Disruptive Behavior Disorders: A Systematic Review of Efficacy and Tolerability (2013) (48)
- Increased SNARE Protein-Protein Interactions in Orbitofrontal and Anterior Cingulate Cortices in Schizophrenia (2015) (47)
- Synaptic Proteins and Choline Acetyltransferase Loss in Visual Cortex in Dementia With Lewy Bodies (2013) (47)
- Association between schizophrenia and the syntaxin 1A gene (2004) (46)
- Structural brain changes are associated with response of negative symptoms to prefrontal repetitive transcranial magnetic stimulation in patients with schizophrenia (2017) (45)
- Clozapine-Induced Cardiovascular Side Effects and Autonomic Dysfunction: A Systematic Review (2018) (44)
- The SORL1 Gene and Convergent Neural Risk for Alzheimer's Disease Across the Human Lifespan (2013) (44)
- PSYCHOSIS AND VIOLENCE IN COCAINE SMOKERS (1987) (44)
- Clozapine augmentation strategies – a systematic meta-review of available evidence. Treatment options for clozapine resistance (2019) (44)
- A Qualitative and Quantitative Study of Grumose Degeneration in Progressive Supranuclear Palsy (2000) (44)
- The genomic era and serious mental illness: a potential application for psychiatric genetic counseling. (2007) (43)
- T204. CLOZAPINE COMBINATION AND AUGMENTATION STRATEGIES IN PATIENTS WITH SCHIZOPHRENIA –RECOMMENDATIONS FROM AN INTERNATIONAL EXPERT SURVEY AMONG THE TREATMENT RESPONSE AND RESISTANCE IN PSYCHOSIS (TRRIP) WORKING GROUP (2020) (43)
- The Genetic and Environmental Basis of the Relationship Between Schizotypy and Personality: A Twin Study (2005) (41)
- Treatment of a first episode of psychotic illness with quetiapine: An analysis of 2 year outcomes (2006) (41)
- Reduction of the Internal Capsule in Families Affected with Schizophrenia (2008) (41)
- Regional Cortical Anatomy and Clozapine Response in Refractory Schizophrenia (1995) (40)
- Automated image analysis of disturbed cytoarchitecture in Brodmann area 10 in schizophrenia (2003) (40)
- Loss of synaptophysin and synaptosomal‐associated protein 25‐kDa (SNAP‐25) in elderly Down syndrome individuals (2007) (40)
- Medication errors in psychiatry (2010) (40)
- α‐Synuclein Inclusions in Alzheimer and Lewy Body Diseases (2000) (39)
- Prolongation of clozapine-induced granulocytopenia associated with olanzapine. (1997) (39)
- Routine exercise ameliorates the metabolic side-effects of treatment with the atypical antipsychotic drug olanzapine in rats. (2014) (39)
- Temporal lobe abnormalities in multigenerational families with schizophrenia (1994) (39)
- Presynaptic proteins and schizophrenia. (2004) (39)
- NCAM and schizophrenia: genetic studies (1997) (38)
- THE USE OF RISPERIDONE IN SEVERELY DEMENTED PATIENTS WITH PERSISTENT VOCALIZATIONS (1997) (38)
- Metabolic Side-Effects of the Novel Second-Generation Antipsychotic Drugs Asenapine and Iloperidone: A Comparison with Olanzapine (2013) (38)
- Hippocampal Subfield Volumes in First Episode and Chronic Schizophrenia (2015) (38)
- Synaptic protein deficits are associated with dementia irrespective of extreme old age (2012) (38)
- A longitudinal study on the effects of typical versus atypical antipsychotic drugs on hippocampal volume in schizophrenia (2007) (37)
- Unirhinal olfactory identification deficits in young male patients with schizophrenia and related disorders: association with impaired memory function (2002) (37)
- The hippocampus in families with schizophrenia in relation to obstetric complications (2008) (37)
- Pharmacological treatment of antipsychotic-induced dyslipidemia and hypertension (2014) (37)
- Consensus statement on the use of clozapine during the COVID-19 pandemic. (2020) (37)
- 48 echo T2 myelin imaging of white matter in first-episode schizophrenia: Evidence for aberrant myelination (2014) (36)
- Smaller corpus callosum subregions containing motor fibers in schizophrenia (2005) (36)
- Topographical distribution of synaptic-associated proteins in the neuritic plaques of Alzheimer's disease hippocampus (2004) (36)
- Regio entorhinalis in schizophrenia: more evidence for migrational disturbances and suggestions for a new biological hypothesis. (2003) (35)
- Left nostril olfactory identification impairment in a subgroup of male patients with schizophrenia (1998) (35)
- Mortality from treatable illnesses in marginally housed adults: a prospective cohort study (2015) (34)
- Mood stabilizer lithium inhibits amphetamine-increased 4-hydroxynonenal-protein adducts in rat frontal cortex. (2012) (34)
- A meta-analysis of profile and time-course of symptom change in acute schizophrenia treated with atypical antipsychotics. (2006) (34)
- Search for unstable DNA in schizophrenia families with evidence for genetic anticipation. (1996) (34)
- Hippocampal volume and the brain-derived neurotrophic factor Val66Met polymorphism in first episode psychosis (2012) (33)
- Diagnostic confusion in treatment-refractory psychotic patients. (1992) (33)
- Selective effects of typical antipsychotic drugs on SNAP-25 and synaptophysin in the hippocampal trisynaptic pathway. (2006) (33)
- Efficacy and safety of clozapine in psychotic disorders—a systematic quantitative meta-review (2021) (33)
- Influence of genetic loading, obstetric complications and premorbid adjustment on brain morphology in schizophrenia: (2003) (33)
- Reduced thalamic volume in patients with chronic schizophrenia after switching from typical antipsychotic medications to olanzapine. (2006) (32)
- Analysis of postmortem ventricular cerebrospinal fluid from patients with and without dementia indicates association of vitamin E with neuritic plaques and specific measures of cognitive performance. (2011) (32)
- Lewy Body Variant of Alzheimer's Disease: Selective Neocortical Loss of t-SNARE Proteins and Loss of MAP2 and α-Synuclein in Medial Temporal Lobe (2009) (32)
- Presynaptic proteins complexin-I and complexin-II differentially influence cognitive function in early and late stages of Alzheimer’s disease (2017) (31)
- In vitro synaptotrophic effects of Cerebrolysin in NT2N cells (1999) (31)
- Association between myelin basic protein expression and left entorhinal cortex pre-alpha cell layer disorganization in schizophrenia (2009) (31)
- A family-based association study of the myelin-associated glycoprotein and 2′,3′-cyclic nucleotide 3′-phosphodiesterase genes with schizophrenia (2008) (30)
- Loss of Munc18-1 long splice variant in GABAergic terminals is associated with cognitive decline and increased risk of dementia in a community sample (2015) (30)
- Low birthweight in schizophrenia: prematurity or poor fetal growth? (2001) (30)
- Rapid Change in Fentanyl Prevalence in a Community-Based, High-Risk Sample (2018) (30)
- Mutagenic activity of swimming-pool water. (1980) (30)
- Schizophrenia and severe tardive dyskinesia responsive to risperidone. (1994) (30)
- White matter deficits assessed by diffusion tensor imaging and cognitive dysfunction in psychostimulant users with comorbid human immunodeficiency virus infection (2015) (29)
- Conceptual and Methodological Issues in the Design of Clinical Trials of Antipsychotics for the Treatment of Schizophrenia (2007) (29)
- A translational research approach to poor treatment response in patients with schizophrenia: clozapine-antipsychotic polypharmacy. (2009) (28)
- Treatment delay and pathways to care in early psychosis (2014) (28)
- Olfactory identification and psychosis (1999) (28)
- The temporal lobe in schizophrenia from uni- and multiply affected families (2002) (27)
- Tolerance to the anhedonic effects of lipopolysaccharide is associated with changes in syntaxin immunoreactivity in the nucleus accumbens. (2003) (27)
- The Hotel Study—Clinical and Health Service Effectiveness in a Cohort of Homeless or Marginally Housed Persons (2017) (27)
- Effects of chronic exercise and treatment with the antipsychotic drug olanzapine on hippocampal volume in adult female rats (2013) (27)
- Predicting 1-year risk for relapse in patients who have discontinued or continued quetiapine after remission from first-episode psychosis (2013) (27)
- Targeting Synaptic Pathology with a Novel Affinity Mass Spectrometry Approach* (2014) (26)
- Relationship between frontostriatal morphology and executive function deficits in bipolar I disorder following a first manic episode: data from the Systematic Treatment Optimization Program for Early Mania (STOP‐EM) (2013) (26)
- Cortical cholinergic denervation elicits vascular A beta deposition. (2000) (26)
- Canadian Guidelines for the Assessment and Diagnosis of Patients with Schizophrenia Spectrum and Other Psychotic Disorders (2017) (26)
- Sex differences in cognitive functioning in patients with bipolar disorder who recently recovered from a first episode of mania: data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM). (2014) (26)
- Antidiabetic-drug combination treatment for glucose intolerance in adult female rats treated acutely with olanzapine (2014) (26)
- A randomized, double-blind, placebo-controlled study of the safety and tolerability of high-dose quetiapine in patients with persistent symptoms of schizophrenia or schizoaffective disorder. (2012) (26)
- Assessing the machinery of mind: synapses in neuropsychiatric disorders. (1999) (25)
- Neuropsychological Correlates of the PANSS Cognitive Factor (2004) (25)
- Predictors of starting to smoke cigarettes in patients with first episode psychosis (2009) (25)
- Predictors of Treatment-Resistant and Clozapine-Resistant Schizophrenia: A 12-Year Follow-up Study of First-Episode Schizophrenia-Spectrum Disorders. (2020) (25)
- The temporal lobes, reversed asymmetry and the genetics of schizophrenia (1995) (25)
- Prenatal ethanol exposure in rats decreases levels of complexin proteins in the frontal cortex. (2005) (25)
- Characterization of a synaptic antigen of interest in neuropsychiatric illness (1992) (25)
- Impaired musical ability in people with schizophrenia. (2014) (25)
- Cortical morphology and early adverse birth events in men with first-episode psychosis (2014) (24)
- Compartmental volumetry of the superior temporal gyrus reveals sex differences in schizophrenia—a post-mortem study (1998) (24)
- A comparison of psychotic symptoms in subjects with methamphetamine versus cocaine dependence (2017) (23)
- Associations of substance use, psychosis, and mortality among people living in precarious housing or homelessness: A longitudinal, community-based study in Vancouver, Canada (2020) (23)
- Testing Liddle's three-syndrome model in families with schizophrenia (1994) (23)
- Frontotemporal dysregulation of the SNARE protein interactome is associated with faster cognitive decline in old age (2018) (23)
- Patterns of dysmorphic features in schizophrenia. (2001) (23)
- Hippocampal volume and vasculature before and after exercise in treatment-resistant schizophrenia (2018) (23)
- Neurocognitive profiles of marginally housed persons with comorbid substance dependence, viral infection, and psychiatric illness (2014) (22)
- Paliperidone Palmitate Long-Acting Injectable Given Intramuscularly in the Deltoid Versus the Gluteal Muscle: Are They Therapeutically Equivalent? (2015) (22)
- Symptom changes in five dimensions of the Positive and Negative Syndrome Scale in refractory psychosis (2014) (22)
- Genetic counseling for schizophrenia: A review of referrals to a provincial medical genetics program from 1968 to 2007 (2010) (22)
- Mania and depression in the perinatal period among women with a history of major depressive disorders (2014) (22)
- SP1 regulates a human SNAP‐25 gene expression (2008) (22)
- Tau Proteins in the Temporal and Frontal Cortices in Patients With Vascular Dementia (2015) (21)
- Donepezil for memory dysfunction in schizophrenia (2002) (21)
- Weight gain as a predictor of frontal and temporal lobe volume loss in bipolar disorder: A prospective MRI study (2018) (21)
- Traumatic Brain Injury in a Community-Based Cohort of Homeless and Vulnerably Housed Individuals. (2017) (20)
- ApoE and cholesterol in schizophrenia and bipolar disorder: comparison of grey and white matter and relation with APOE genotype. (2011) (20)
- Early-onset schizophrenia in children with mental retardation: diagnostic reliability and stability of clinical features. (2003) (20)
- White matter tract abnormalities in first-episode psychosis (2012) (20)
- Olfactory deficits in patients with schizophrenia and severe polydipsia (1998) (20)
- Association between Serum Lipids and Antipsychotic Response in Schizophrenia (2019) (20)
- Childhood maltreatment and corpus callosum volume in recently diagnosed patients with bipolar I disorder: data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM). (2014) (20)
- A case study of temporal lobe development in familial schizophrenia (1996) (19)
- Clozapine-induced obsessive–compulsive symptoms: mechanisms and treatment (2019) (19)
- Relationship between body mass index and hippocampal glutamate/glutamine in bipolar disorder. (2016) (19)
- Prevalence and Patterns of Antipsychotic Use in Youth at the Time of Admission and Discharge From an Inpatient Psychiatric Facility (2014) (19)
- Antipsychotic polypharmacy increases metabolic dysregulation in female rats. (2013) (19)
- Monoclonal antibodies to study the brain in schizophrenia (1989) (18)
- Absence of linkage for schizophrenia on the short arm of chromosome 5 in multiplex Canadian families. (1997) (18)
- Neurocognitive risk markers in pediatric obsessive-compulsive disorder. (2019) (18)
- An Evaluation of the Effects of the Novel Antipsychotic Drug Lurasidone on Glucose Tolerance and Insulin Resistance: A Comparison with Olanzapine (2014) (18)
- Diagnosis and body mass index effects on hippocampal volumes and neurochemistry in bipolar disorder (2017) (18)
- Elevated clozapine levels and toxic effects after SARS-CoV-2 vaccination (2021) (18)
- Deficits in axon‐associated proteins in prefrontal white matter in bipolar disorder but not schizophrenia (2016) (17)
- Factors affecting severity of positive and negative symptoms of psychosis in a polysubstance using population with psychostimulant dependence (2016) (17)
- Shape changes in prefrontal, but not parieto-occipital regions: brains of schizophrenic patients come closer to a circle in coronal and sagittal view (2004) (17)
- Quantitative mass spectrometry reveals changes in SNAP-25 isoforms in schizophrenia (2016) (17)
- Characterization of white matter integrity deficits in cocaine‐dependent individuals with substance‐induced psychosis compared with non‐psychotic cocaine users (2017) (17)
- S49. EFFICACY OF HIGH-FREQUENCY REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION ON PANSS FACTORS IN SCHIZOPHRENIA WITH PREDOMINANT NEGATIVE SYMPTOMS – RESULTS FROM AN EXPLORATORY RE-ANALYSIS (2018) (17)
- A Focused Review of the Metabolic Side-Effects of Clozapine (2021) (17)
- Antipsychotic Medications: Linking Receptor Antagonism to Neuropsychological Functioning in First Episode Psychosis (2012) (17)
- Cognitive decline and mortality in a community-based sample of homeless and precariously housed adults: 9-year prospective study (2020) (16)
- Clozapine-Associated Obsessive-Compulsive Symptoms and Their Management: A Systematic Review and Analysis of 107 Reported Cases (2019) (16)
- Concurrent Disorder Management Guidelines. Systematic Review (2020) (16)
- Perinatal psychosis in mothers with a history of major depressive disorder (2016) (16)
- Clinical and functional characteristics of young adults living in single room occupancy housing: preliminary findings from a 10-year longitudinal study (2018) (16)
- Exercise prevents downregulation of hippocampal presynaptic proteins following olanzapine-elicited metabolic dysregulation in rats: Distinct roles of inhibitory and excitatory terminals (2015) (16)
- Decreased cortical FADD protein is associated with clinical dementia and cognitive decline in an elderly community sample (2017) (16)
- Descriptive and numeric estimation of risk for psychotic disorders among affected individuals and relatives: Implications for clinical practice (2012) (16)
- Mindfulness intervention for mild cognitive impairment led to attention-related improvements and neuroplastic changes: Results from a 9-month randomized control trial. (2021) (15)
- Clozapine, elevated heart rate and QTc prolongation. (2018) (15)
- Predicting first-episode psychosis patients who will never relapse over 10 years (2018) (15)
- The Pharmacokinetics of Second-Generation Long-Acting Injectable Antipsychotics: Limitations of Monograph Values (2015) (15)
- Visual working memory deterioration preceding relapse in psychosis (2016) (15)
- A quantitative review of the profile and time course of symptom change in schizophrenia treated with clozapine (2012) (15)
- Yoga reduces the brain's amplitude of low-frequency fluctuations in patients with early psychosis results of a randomized controlled trial (2017) (15)
- Efficacy of high-frequency repetitive transcranial magnetic stimulation in schizophrenia patients with treatment-resistant negative symptoms treated with clozapine (2019) (14)
- A comparison of antipsychotic drug-defined daily doses versus chlorpromazine equivalent doses in patients with or without extrapyramidal motor symptoms. (2010) (14)
- A systematic review of the effects of CYP2D6 phenotypes on risperidone treatment in children and adolescents (2018) (14)
- Profiles of individuals seeking psychiatric help for psychotic symptoms linked to methamphetamine abuse – baseline results from the MAPS (methamphetamine and psychosis study) (2010) (14)
- Social and structural factors associated with substance use within the support network of adults living in precarious housing in a socially marginalized neighborhood of Vancouver, Canada (2019) (14)
- Relation between cerebrospinal fluid, gray matter and white matter changes in families with schizophrenia. (2006) (14)
- Antipsychotic-Associated Symptoms of Tourette Syndrome: A Systematic Review (2018) (14)
- Structural Brain Markers Are Differentially Associated With Neurocognitive Profiles in Socially Marginalized People With Multimorbid Illness (2017) (14)
- Chronic elevation of amyloid precursor protein in the neocortex or hippocampus of marmosets with selective cholinergic lesions (2001) (14)
- Efficacy of long‐acting injectable versus oral antipsychotic drugs in early psychosis: A systematic review and meta‐analysis (2021) (14)
- Student-directed teaching of medical ethics at a Canadian medical school. (1985) (13)
- Mutagenicactivity of swimming-pool water. (1980) (13)
- Increased head circumference in schizophrenia (1996) (13)
- Differential Effects of Acute Treatment With Antipsychotic Drugs on Peripheral Catecholamines (2020) (13)
- Structural brain changes in first episode mania with and without psychosis: Data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM) (2018) (13)
- Rapid Agitation Control With Ketamine in the Emergency Department: A Blinded, Randomized Controlled Trial. (2021) (13)
- Clozapine administered once versus twice daily: does it make a difference? (2014) (13)
- The Positive and Negative Syndrome Scale (PANSS): A Three-Factor Model of Psychopathology in Marginally Housed Persons with Substance Dependence and Psychiatric Illness (2016) (13)
- The synaptic pathology of cognitive life (2019) (13)
- Relationships Among Depression, PTSD, Methamphetamine Abuse, and Psychosis (2013) (13)
- Effects of sub-chronic clozapine and haloperidol administration on brain lipid levels (2010) (13)
- Effects of physical activity on the symptoms of Tourette syndrome: A systematic review (2018) (12)
- Parcellation of the human hippocampus based on gray matter volume covariance: Replicable results on healthy young adults (2019) (12)
- Fatty acid and vitamin interventions in adults with schizophrenia: a systematic review of the current evidence (2015) (12)
- Developmental abnormalities and cortical sulcal enlargement in psychosis (1995) (12)
- Response trajectories to clozapine in a secondary analysis of pivotal trials support using treatment response to subtype schizophrenia. (2015) (12)
- Changes in hippocampal SNAP-25 expression following afferent lesions (2004) (12)
- Schizencephaly associated with psychosis (1997) (12)
- Personalized Risk Assessment of Drug-Related Harm Is Associated with Health Outcomes (2013) (12)
- Prefrontal fatty acid composition in schizophrenia and bipolar disorder: Association with reelin expression (2017) (12)
- Late‐life physical activity relates to brain tissue synaptic integrity markers in older adults (2022) (11)
- The impact of monetary reward on memory in schizophrenia spectrum disorder. (2007) (11)
- Elevated clozapine plasma concentration secondary to a urinary tract infection: proposed mechanisms. (2016) (11)
- Do serum lipids predict response to clozapine treatment? (2009) (11)
- Microglial correlates of late life physical activity: Relationship with synaptic and cognitive aging in older adults. (2021) (11)
- Synaptic changes in frontotemporal lobar degeneration: correlation with MAPT haplotype and APOE genotype (2011) (11)
- Routine assessment of patient progress: a multiformat, change-sensitive nurses' instrument for assessing psychotic inpatients. (1995) (11)
- Obstetric complications and severity of illness in schizophrenia [ (1995) (11)
- No effect of naloxone on plasma oxytocin in normal men (1986) (10)
- The physician-scientist in Canadian psychiatry. (2004) (10)
- Reversal of Dopamine Supersensitivity as a Mechanism of Action of Clozapine (2018) (10)
- A centralized system for monitoring clozapine use in British Columbia. (1996) (10)
- Reduced SNAP25 Protein Fragmentation Contributes to SNARE Complex Dysregulation in Schizophrenia Postmortem Brain (2019) (10)
- Subcortical structural volumes in recently remitted first episode mania. (2017) (10)
- A comparison of regional brain volumes and white matter connectivity in subjects with stimulant induced psychosis versus schizophrenia (2019) (10)
- Characterization of mental health in cannabis dispensary users, using structured clinical interviews and standardized assessment instruments (2019) (10)
- Subcortical grey matter alterations in cocaine dependent individuals with substance-induced psychosis compared to non-psychotic cocaine users (2016) (10)
- 31 Panss symptom factors in schizophrenia (1997) (10)
- Effects of Exercise on Serum Triglycerides and Symptoms of Schizophrenia (2017) (10)
- A comparison of the effects of clozapine and its metabolite norclozapine on metabolic dysregulation in rodent models (2020) (10)
- Cognitive profiles and associated structural brain networks in a multimorbid sample of marginalized adults (2019) (10)
- Cognitive Impairment in Marginally Housed Youth: Prevalence and Risk Factors (2019) (10)
- PERSONALITY FEATURES AND DISORDER IN THE SUBJECTS IN THE NEW YORK HIGH-RISK PROJECT. (1993) (10)
- Left prefrontal high-frequency rTMS may improve movement disorder in schizophrenia patients with predominant negative symptoms – A secondary analysis of a sham-controlled, randomized multicenter trial (2019) (9)
- Antipsychotic prescribing patterns on admission to and at discharge from a tertiary care program for treatment-resistant psychosis (2018) (9)
- Musical disability in children with autism spectrum disorder (2018) (9)
- Long-acting injectable antipsychotics for early psychosis: A comprehensive systematic review (2022) (9)
- Adrenoleukodystrophy associated with psychosis. (2000) (9)
- Clinical features of schizophrenia in a woman with hyperandrogenism. (1997) (9)
- Proposing the Use of Partial AUC as an Adjunctive Measure in Establishing Bioequivalence Between Deltoid and Gluteal Administration of Long-Acting Injectable Antipsychotics (2016) (9)
- Spines, Synapses, and Schizophrenia (2015) (9)
- Volumes of the Hippocampal Formation Differentiate Component Processes of Memory in a Community Sample of Homeless and Marginally Housed Persons. (2018) (8)
- Left cerebral hemiatrophy and schizophrenia-like psychosis in an adolescent (1996) (8)
- Tripartite Relationship Among Synaptic, Amyloid, and Tau Proteins (2021) (8)
- Cognition and Plasma Ratio of Clozapine to N-desmethylclozapine in Patients With Clozapine-Resistant Schizophrenia. (2015) (8)
- The SNAP25 Interactome in Ventromedial Caudate in Schizophrenia Includes the Mitochondrial Protein ARF1 (2019) (8)
- Measurement of the GH and other responses to clonidine at different times of the day in normal subjects (1984) (8)
- Prevalence and Risk Factors of Brain Infarcts and Associations With Cognitive Performance in Tenants of Marginal Housing (2019) (8)
- PCO2 modulation of ventilation and HCO3- buffer during chronic metabolic acidosis. (1983) (7)
- Differential effects of cannabis exposure during early versus later adolescence on the expression of psychosis in homeless and precariously housed adults (2020) (7)
- Letter to the Editor: Influence of rTMS on smoking in patients with schizophrenia (2017) (7)
- Reduced cardiovascular fitness associated with exposure to clozapine in individuals with chronic schizophrenia (2018) (7)
- Breakthrough symptoms after switching long-acting injectable paliperidone palmitate from the gluteal to the deltoid site of administration. (2016) (7)
- Rapid agitation control with ketamine in the emergency department (RACKED): a randomized controlled trial protocol (2018) (7)
- Etiopathogenetic mechanisms in long-term course of schizophrenia. (2004) (7)
- Efficacy and tolerability of aripiprazole versus D2 antagonists in the early course of schizophrenia: a systematic review and meta-analysis (2021) (7)
- Linkage analysis between schizophrenia and the Darier's disease region on 12q (1996) (7)
- Red blood cell folate levels in pregnant women with a history of mood disorders: a case series. (2013) (7)
- Excessive antipsychotic dosing in a Canadian outpatient population. (2011) (7)
- Repetitive transcranial magnetic stimulation (rTMS) for schizophrenia patients treated with clozapine (2020) (7)
- Exercise-induced hippocampal neurogenesis: 5-HT3 receptor antagonism by antipsychotics as a potential limiting factor in Schizophrenia (2018) (7)
- Cerebral Small Vessel Disease, Risk Factors, and Cognition in Tenants of Precarious Housing (2020) (7)
- Musical deficits and cortical thickness in people with schizophrenia (2018) (7)
- THE IMPACTS OF YOGA AND AEROBIC EXERCISE ON NEURO-COGNITION AND BRAIN STRUCTURE IN EARLY PSYCHOSIS – A PRELIMINARY ANALYSIS OF THE RANDOMIZED CONTROLLED CLINICAL TRIAL (2012) (6)
- Psychopharmacology for the Clinician Psychopharmacologie pratique (2009) (6)
- Complexins I and II in hippocampus in schizophrenia (2003) (6)
- Suicide Deaths in British Columbia during the First Wave of the COVID-19 Pandemic (2021) (6)
- Diagnostic reassessment and treatment response in schizophrenia. (1994) (6)
- Alcohol Consumption Does not Impede Recovery from Mild to Moderate Traumatic Brain Injury (2016) (6)
- Development of a cost‐efficient novel method for rapid, concurrent genotyping of five common single nucleotide polymorphisms of the brain derived neurotrophic factor (BDNF) gene by tetra‐primer amplification refractory mutation system (2015) (6)
- Converging lateralized olfactory and neuropsychological deficits in male patients with schizophrenia (1995) (5)
- A comparison of the metabolic side-effects of the second-generation antipsychotic drugs risperidone and paliperidone in animal models (2021) (5)
- Lateral asymmetry in the shape of brain ventricles in control and schizophrenia groups (2006) (5)
- Cerebrovascular and microglial states are not altered by functional neuroinflammatory gene variant (2016) (5)
- Two RFLPs near HOX2@/NGFR at locus D17S444E. (1992) (5)
- Dopamine receptor D3R and D4R mRNA levels in peripheral lymphocytes in patients with schizophrenia correlate with severity of illness (2011) (5)
- Automated gray level index measurements reveal only minor cytoarchitectonic changes of Brodmann area 9 in schizophrenia (2008) (5)
- Diffusion tensor imaging of neurocognitive profiles in a community cohort living in marginal housing (2019) (5)
- Factors Associated With Successful Medication Discontinuation After a Randomized Clinical Trial of Relapse Prevention in First-Episode Psychosis: A 10-Year Follow-up (2019) (5)
- Amygdala Nuclei Volumes Are Selectively Associated With Social Network Size in Homeless and Precariously Housed Persons (2020) (5)
- Disturbed gyrification and reduced volume of the prefrontal lobe in male schizophrenics—A morphometric postmortem study (1998) (5)
- Medial temporal lobe cortical changes in response to exercise interventions in people with early psychosis: A randomized controlled trial (2020) (5)
- Prenatal tobacco exposure in first-episode psychosis (2010) (5)
- Poster #M193 THE IMPACTS OF AEROBIC EXERCISE AND MIND-BODY EXERCISE (YOGA) ON NEURO-COGNITION AND CLINICAL SYMPTOMS IN EARLY PSYCHOSIS – A SINGLE-BLIND RADOMIZED CONTROLLED CLINICAL TRIAL (2014) (5)
- Second replication of disturbed pre-alpha-cell migration in the entorhinal cortex of schizophrenic patients (2003) (5)
- Brain IGFBP-5 modifies the relation of depressive symptoms to decline in cognition in older persons. (2019) (5)
- Verbal memory improvement in first-episode psychosis APOE-ε4 carriers: a pleiotropic effect? (2017) (5)
- Long-acting injectable risperidone in treatment refractory patients: A 14-week open-label pilot study (2010) (4)
- Three-year outcome of phase-specific early intervention for first-episode psychosis: a cohort study in Hong Kong. (2012) (4)
- Managing ADHD and disruptive behaviour disorders with combination psychostimulant and antipsychotic treatment. (2014) (4)
- Structural brain imaging abnormalities associated with schizophrenia and partial trisomy of chromosome 5 (1992) (4)
- MAG Gene Variation and Cortical Gray Matter Volume in First Episode Schizophrenia (2008) (4)
- Hippocampal synaptic pathology in patients with temporal lobe epilepsy (1994) (4)
- Heart-rate response to alpha2-adrenergic receptor antagonism by antipsychotics (2017) (4)
- Proteomic identification of select protein variants of the SNARE interactome associated with cognitive reserve in a large community sample (2021) (4)
- A prospective study to explore the relationship between MTHFR C677T genotype, physiological folate levels, and postpartum psychopathology in at-risk women (2020) (4)
- Brain γ-Tocopherol Levels Are Associated with Presynaptic Protein Levels in Elderly Human Midfrontal Cortex (2020) (4)
- A randomized placebo controlled double blind trial of augmentation of clozapine with risperidone (2005) (4)
- Characterizing Traumatic Brain Injury and Its Association with Losing Stable Housing in a Community-based Sample (2021) (4)
- The Impacts of Yoga On Cortical Thickness, Neural Connectivity and Cognitive Function in Early Psychosis: Preliminary Results From a Randomized Controlled Clinical Trial (2015) (4)
- Dopamine D4 receptor gene variants and schizophrenia (1993) (4)
- A double-blind randomized placebo-controlled study of relapse prevention in remitted first-episode psychosis patients following one year of maintenance therapy (2008) (3)
- THE EFFECTS OF PHYSICAL EXERCISE ON BRAIN MORPHOLOGY IN PATIENTS WITH SCHIZOPHRENIA (2008) (3)
- Loss of Munc18-1 long splice variant in GABAergic terminals is associated with cognitive decline and increased risk of dementia in a community sample (2015) (3)
- A DOUBLE BLIND, PLACEBO CONTROLLED STUDY OF THE SAFETY AND TOLERABILITY OF QUETIAPINE 1200 MG/D VERSUS 800 MG/D IN PATIENTS WITH PERSISTENT SYMPTOMS OF SCHIZOPHRENIA OR SCHIZOAFFECTIVE DISORDER (2010) (3)
- Statin add-on therapy for schizophrenia: Is the effect the same for clozapine? (2018) (3)
- Association of serial position scores on memory tests and hippocampal-related neuropathologic outcomes (2020) (3)
- S.17.01 A randomized controlled trial of antipsychotic polypharmacy: clozapine plus risperidone (2007) (3)
- Analysis of the ratio of calretinin-expressing interneurons and pyramidal neurons in the hippocampus of patients with schizophrenia (1999) (3)
- Organic Affective Disorder and Vascular Dysregulation in Systemic Lupus Erythematosus (1989) (3)
- Association of total peripheral inflammation with lower frontal and temporal lobe volumes in early-stage bipolar disorder: A proof-of-concept study. (2022) (3)
- Microsmia in postmenopausal women with genetic vulnerability to psychosis (2003) (3)
- The temporal lobes, reversed asymmetry, and schizophrenia genetics (1996) (3)
- Chronic Treatment With Psilocybin Decreases Changes in Body Weight in a Rodent Model of Obesity (2022) (3)
- Effectiveness and optimal duration of early intervention treatment in adult-onset psychosis: a randomized clinical trial (2022) (3)
- Investigation of genetic risk factors for schizophrenia on 11q (1993) (3)
- 518 A comparison of two atypical antipsychotics in treatment resistant schizoprehnia (1997) (3)
- SS‐Detect: Development and Validation of a New Strategy for Source‐Based Morphometry in Multiscanner Studies (2020) (3)
- Translating genomic research into care for people with schizophrenia in China (2011) (3)
- Obstetric complications and age-related changes in brain morphology in schizophrenia (1996) (3)
- Relevance of Presynaptic Proteins to Neuropsychiatric Disorders (2006) (3)
- The cell junctions of the notochord of Xenopus laevis tadpoles. (1990) (3)
- Synaptic proteins in the granule cell layer in schizophrenic hippocampus (2000) (3)
- COVID-19 Vaccines and the Virus: Impact on Drug Metabolism and Pharmacokinetics (2022) (3)
- Overdose mortality is reducing the gains in life expectancy of antiretroviral-treated people living with HIV in British Columbia, Canada. (2021) (3)
- Aerobic exercise and yoga hold promises for improving neurocognition and symptom in early psychosis (2015) (2)
- Indications of Abnormal Connectivity in Neuropsychiatric Disorders in Postmortem Studies (2002) (2)
- Preliminary examination of the validity of the NIH toolbox cognition battery in treatment-resistant psychosis (2019) (2)
- Search for unstable DNA in schizophrenia (1998) (2)
- A Tetra-Primer Amplification Refractory System Technique for the Cost-Effective and Novel Genotyping of Eight Single-Nucleotide Polymorphisms of the Catechol-O-Methyltransferase Gene. (2016) (2)
- Dimenhydrinate use disorder with chronic psychosis. (2015) (2)
- SA101. Characterization of Presynaptic SNAP-25 Aggregates in Human Postmortem Brain: A Novel Pathologic Index in Schizophrenia? (2017) (2)
- Risk factors for hippocampal cavities in a marginally housed population (2022) (2)
- Exercise and Worsening of Extrapyramidal Symptoms during Treatment with Long-Acting Injectable Antipsychotics (2021) (2)
- Clozapine and COVID-19/respond (2020) (2)
- Methamphetamine, perceptual disturbances, and the peripheral drift illusion. (2011) (2)
- P0137 - A double-blind randomized placebo-controlled study of relapse predictors in remitted first-episode psychosis patients (2008) (2)
- P0093 - A double-blind randomized placebo-controlled relapse prevention study in remitted first-episode psychosis patients following one year of maintanence therapy (2008) (2)
- Clozapine, risperidone and typical antipsychotics in severely ill patients with schizophrenia (1995) (2)
- 443 Progressive brain changes and age at onset of illness in schizophrenia (1997) (2)
- What are Canadian emergency physicians’ attitudes and self-perceived competence toward patients who present with suicidal ideation? (2021) (2)
- Pain, opioid use, depressive symptoms, and mortality in adults living in precarious housing or homelessness: a longitudinal prospective study. (2022) (2)
- First episode psychosis with extrapyramidal signs prior to antipsychotic drug treatment (2011) (2)
- Predictors for relapse in a double-blind randomized placebo-controlled discontinuation study of remitted first-episode psychosis patients (2008) (2)
- Dynamic networks of psychotic symptoms in adults living in precarious housing or homelessness (2021) (2)
- A ganglionic blocker and adrenoceptor ligands modify clozapine-induced insulin resistance (2021) (2)
- An MRI study of basal ganglia volumes in drug-naive first episode schizophrenia patients at baseline and after one year treatment with risperidone (2000) (2)
- 548 Risperidone for first episode schizophrenia: Symptom response to lower, intermediate and higher dose strategies (1997) (2)
- Abnormalities of prefrontal cortex SNARE complex proteins in bipolar disorder (2002) (1)
- Evidence for a locus on chromosome 6p related to positive symptom scores in Canadian families with schizophrenia (1996) (1)
- A new approach to the neurobiology of schizophrenia using monoclonal antibodies (1989) (1)
- Traumatic brain injury in precariously housed persons: Incidence and risks (2022) (1)
- M54. ASSOCIATIONS BETWEEN MUSICAL ABILITY SUBSCALE PERFORMANCE, PSYCHIATRIC SYMPTOMS, AND COGNITIVE FUNCTIONING IN SCHIZOPHRENIA (2020) (1)
- Exercise-associated extrapyramidal symptoms during treatment with long-acting injectable antipsychotic medications: A case report. (2017) (1)
- A comparison of treatment response between early- and adult-onset schizophrenia (1998) (1)
- Symptoms in first episode schizophrenia: Response to risperidone (1995) (1)
- Hippocampal Neurogenesis in Aging and Alzheimer’s Disease. (2022) (1)
- Olfactory deficits in familial schizophrenia (1996) (1)
- Response to the Letter to the Editor on "Paliperidone Palmitate Long-Acting Injectable Given Intramuscularly in the Deltoid Versus the Gluteal Muscle: Are They Therapeutically Equivalent?" (2016) (1)
- Striatal dopamine synthesis capacity and its association with negative symptoms upon resolution of positive symptoms in first-episode schizophrenia and delusional disorder (2022) (1)
- Obstetric complications and age-related changes in brain morphology in schizophrenia (1995) (1)
- Just the Facts: Substance induced psychosis (2020) (1)
- High-Dose Fluvoxamine Augmentation to Clozapine in Treatment-Resistant Psychosis (2021) (1)
- Characterization of Bodily Pain and Use of Both Prescription and Non-Prescription Opioids in Tenants of Precarious Housing (2021) (1)
- Oxidative modification of synaptosomal-associated protein 25 (2012) (1)
- Increased myelin basic protein in BA 10 white matter in schizophrenia (2000) (1)
- O8.4. THE EFFECT OF EARLY MEDICATION DISCONTINUATION ON LONG-TERM CLINICAL OUTCOME IN FIRST EPISODE PSYCHOSIS (2018) (1)
- 402 Cortical surface in schizophrenic patients and controls: MRI, 3-D reconstruction and in vivo morphometry (1997) (1)
- “Differential effects of three classes of antidiabetic drugs on olanzapine-induced glucose dysregulation and insulin resistance in female rats” (2012) (1)
- Neuroanatomical abnormalities in DTI measures associated with auditory hallucinations in schizophrenia (2009) (1)
- 302 Impaired olfactory identification ability and acuity in patients with schizophrenia and severe polydipsia: Evidence for a degenerative process? (1997) (1)
- The computerised tomography rating scale for schizophrenia (CTRSS): Validity and reliability (1996) (1)
- TARGETING SYNAPTIC PATHOLOGY WITH A NOVEL AFFINITY MASS SPECTROMETRY APPROACH (2014) (1)
- Outcome Measurement in Pharmacological Trials: Validity of the Routine Assessment of Patient Progress (RAPP) (2003) (1)
- Can we predict relapse in single episode psychosis patients with stable maintenance treatment for at least one year (2008) (1)
- Linkage studies of two new genes of neuropsychiatric interest (1991) (1)
- Relationship between clozapine dose and severity of obsessive-compulsive symptoms. (2021) (1)
- Respiratory failure after clonazepam and amobarbital. (1986) (1)
- One-year mortality of emergency department patients with substance-induced psychosis (2022) (1)
- An Investigation of Morphometric Changes in the Lateral Ventricles of Schizophrenic Subjects (2003) (1)
- SS-Detect: Development and Validation of a New Strategy for Source-Based Morphometry in Multi-Scanner Studies (2020) (1)
- 26 Aggression among patients with treatment refractory psychoses (1997) (1)
- Traumatic Brain Injury: An Underappreciated Determinant of Health in Individuals Who are Homeless or Precariously Housed. (2020) (1)
- Antipsychotic Drug-Induced Increases in Peripheral Catecholamines are Associated With Glucose Intolerance (2022) (1)
- 65-171 Olfactory fuction in monozygotic twins discordant for schizophrenia (1997) (1)
- Effects of clozapine treatment on the improvement of substance use disorders other than nicotine in individuals with schizophrenia spectrum disorders: A systematic review and meta-analysis (2022) (0)
- 111 Hippocampal presynaptic proteins in schizophrenia (1997) (0)
- SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer’s disease (2014) (0)
- Genetic linkage analysis study of schizophrenia in Canadian families: Clinical assessment results (1991) (0)
- Efficacy and Tolerability of Dopamine D2 Receptor Partial Agonists Versus D2 Receptor Antagonists in Early Psychosis: A Systematic Review and Meta-Analysis (2020) (0)
- Progressive neurocognitive decline in schizophrenia: A diagnostic dilemma for clinicians (2022) (0)
- A COMPARISON TO CONTROLS OF BRAIN STRUCTURE IN SUBJECTS WITH METHAMPHETAMINE PSYCHOSIS AND COMORBID HIV INFECTION (2010) (0)
- Genetic testing of the neurodevelopment hypothesis of schizophrenia (1995) (0)
- BrainNet Europe International Conference on Human Brain Tissue Research (2006) (0)
- An MRI study of internal capsule and thalamus in first-episode and chronic schizophrenia (2003) (0)
- Nostalgia: A Swiss Disease (1994) (0)
- EFFECTS OF INDOOR CYCLING ON HIPPOCAMPAL STRUCTURE, METABOLISM AND CLINICAL FEATURES OF SCHIZOPHRENIA (2012) (0)
- The impacts of Yoga and Aerobic Exercise on neuro-cognitive functioning in Early Psychosis — a preliminary analysis of the Randomised Controlled Clinical Trial (2012) (0)
- Impact of medications, mood state, and electrode placement on ECT outcomes in treatment-refractory psychosis (2022) (0)
- Modifying medical trainees' perspectives on vulnerable populations through engagement in community-based team sports : fostering the Health Advocate role (2017) (0)
- EPA-1637 – Effects of Aerobic Exercise on Brain Structure and Function in Schizophrenia (2014) (0)
- Gender differences in Sylvian fissure asymmetry in multiplex families affected with schizophrenia (2000) (0)
- Delineating a 22q11 deletion subtype of schizophrenia (1998) (0)
- 97 The frontal lobe in schizophrenics and control subjects: A volumetric post-mortem-study (1997) (0)
- TU71. SIGNIFICANT INCIDENCE OF RARE CHROMOSOMAL AND GENOMIC SEQUENCE VARIANTS IN HIGHLY TREATMENT-RESISTANT SCHIZOPHRENIA AND SCHIZOAFFECTIVE DISORDER (2021) (0)
- Brain tocopherol levels are inversely associated with Alzheimer's disease neuropathology in humans (2012) (0)
- Loss of synaptic, but not cytoskeletal proteins in the cerebellum of people with chronic schizophrenia (2001) (0)
- Asociar antipsicóticos es ¿eficaz? (2006) (0)
- 160. Comparison of Frontal Cortical Volumes With Physical Fitness in Chronic Schizophrenia Patients Following Aerobic and Resistance Training Programs. (2017) (0)
- M81. Atypical Antipsychotic Dose-Dependent Effects on Fractional Anisotropy in a Cohort of Chronic Schizophrenia Patients. (2017) (0)
- Healthcare utilisation and costs associated with adherence to antipsychotics among people living with HIV/AIDS and schizophrenia: a population-based cohort study in British Columbia, Canada (2023) (0)
- Replication of Liddle's three syndromes in a familial sample (1993) (0)
- Decreased cortical FADD protein is associated with clinical dementia and cognitive decline in an elderly community sample (2017) (0)
- Relapse predictors for discontinuing and continuing maintenance medication in remitted first-episode psychosis patients (2009) (0)
- Component Processes of Decision Making in a Community Sample of Precariously Housed Persons: Associations With Learning and Memory, and Health-Risk Behaviors (2021) (0)
- Obstetric complications in severe psychosis (1992) (0)
- SA115THE UBC MAGERS STUDY OF SEVERELY TREATMENT-RESISTANT PSYCHOSIS: CHROMOSOMAL MICROARRAY FINDINGS IN THE FIRST 25 CASES (2019) (0)
- Society for Neuroscience--31st annual meeting: psychosis. (2001) (0)
- UNDERSTANDING OF MUSICAL IMPAIRMENT MAY FACILITATE THE DEVELOPMENT OF INSIGHT FOR COGNITIVE REMEDIATION (2014) (0)
- The influence of birth complications on cerebral morphology in multiple affected families with schizophrenia (2000) (0)
- Attitudes Toward Schizophrenia Survey (2012) (0)
- Cognitive impairment and genetic risk in familial schizophrenia: Assessment of performance on the mini-mental state examination (MMSE) (1998) (0)
- Longitudinal change in serial position scores in older adults with entorhinal and hippocampal neuropathologies. (2022) (0)
- Decreased medial entorhinal cortical thickness in olanzapine exposed female rats is not ameliorated by exercise (2019) (0)
- Effectsofendurancetrainingonbrainstructuresinchronicschizophrenia patients and healthy controls (2016) (0)
- SOCIAL FUNCTIONING SCALE FOR PSYCHOSIS IN THE CHINESE SETTING: A PRELIMINARY PSYCHOMETRIC STUDY (2009) (0)
- Brain tau in ischaemic injury and vascular dementia (2014) (0)
- Subjective cognitive functioning, depressive symptoms, and objective cognitive functioning in people with treatment-resistant psychosis (2022) (0)
- Yoga and aerobic exercise in early psychosis: neurocognitive effects and brain changes of a novel clinical strategy (2013) (0)
- Obstetric complications and brain changes in schizophrenia (1996) (0)
- SERUM LONG-CHAIN N-3 FATTY ACID LEVELS ARE ASSOCIATED WITH PRESYNAPTIC PROTEINS IN THE HUMAN BRAIN (2017) (0)
- UBC DEPARTMENT OF PSYCHIATRY (2020) (0)
- A translational medicine approach to molecular psychiatry (2012) (0)
- Gene-Gene Interaction Within an Early Risk Pathway for Alzheimer's Disease Predicts Cortical Thickness and Cerebral Infarcts (2014) (0)
- Pathways into care in early psychosis (2003) (0)
- 0401 ALTERATIONS IN SYNAPTIC PROTEINS IN THE GRANULE CELL LAYER OF THE HIPPOCAMPUS IN SCHIZOPHRENIA ARE RELATED TO COGNITIVE IMPAIRMENT, AND MAY REFLECT THE INFLUENCE OF EARLY DEVELOPMENTAL PROCESSES (2006) (0)
- 412 Asymmetry of the middle cranial fossa in schizophrenia, temporal lobe epilepsy and controls (1997) (0)
- GENDER DIFFERENCES IN SEVERELY ILL PSYCHOTIC PATIENTS (1992) (0)
- Aerobic Exercise and Mind-body Exercise (Yoga): neurocognitive and clinical effects of a novel treatment (2014) (0)
- COMPILATION OF AN INTERDISCIPLINARY LONGITUDINAL TREATMENT HISTORY FOR COMPLEX PATIENTS WITH PSYCHOSIS (2008) (0)
- Using serial position effects to investigate memory dysfunction in homeless and precariously housed persons. (2023) (0)
- Title Aerobic Exercise and Yoga Improve NeuroCognitive Function inWomen with Early Psychosis (2015) (0)
- Proposing the Use of Partial AUC as an Adjunctive Measure in Establishing Bioequivalence Between Deltoid and Gluteal Administration of Long-Acting Injectable Antipsychotics (2016) (0)
- 421 Sylvian fissure and middle cranial fossae asymmetries in families with schizophrenia (1997) (0)
- A follow-up study of basal ganglia volumes and extrapyramidal symptoms in schizophrenia patients treated with risperidone or olanzapine (2003) (0)
- Co-occurring psychosis, substance related disorders, and viral infection in a socially disadvantaged population: preliminary results (2011) (0)
- White matter deficits assessed by diffusion tensor imaging and cognitive dysfunction in psychostimulant users with comorbid human immunodeficiency virus infection (2015) (0)
- SUBSTANCE ABUSE AS A RISK FACTOR FOR FIRST EPISODE PSYCHOSIS (2008) (0)
- What is the risk of returning to the emergency department within 30 days for patients diagnosed with substance-induced psychosis? (2022) (0)
- F179. NEURAL CORRELATES IN MUSICAL DEFICITS IN SCHIZOPHRENIA (2018) (0)
- M55. STRUCTURAL CHANGES RELEVANT TO MUSICAL DEFICITS IN SCHIZOPHRENIA (2020) (0)
- Abstract WMP49: White Matter Hyperintensities in a High Risk Population Living in Marginal Housing (HOTEL study) (2017) (0)
- 135 A susceptibility locus for schizophrenia on chromosome 6 using positive symptom scores as quantitative traits (1997) (0)
- 0460 ABNORMALITIES OF SUBREGIONAL MYELINATION IN FIRST-EPISODE PSYCHOSIS PATIENTS USING MYELIN WATER IMAGING (2006) (0)
- Poster #154 NEUROCOGNITIVE PROFILES OF MARGINALIZED PERSONS WITH COMORBID PSYCHOSIS AND POLYSUBSTANCE ABUSE (2012) (0)
- Schizophrenia with movement disorder prior to treatment (2002) (0)
- Cortical Cholinergic Deafferentation Induces Aβ Deposition (2005) (0)
- F104CHROMOSOMAL MICROARRAYS IMPLICATE GENES REGULATING DENDRITOGENESIS – POTENTIAL IMPLICATIONS FOR PRECISION MEDICINE IN BIPOLAR DISORDER AND SCHIZOPHRENIA (2019) (0)
- Reproductive fitness in familial schizophrenia (1995) (0)
- A change-sensitive nurses' scale to assess psychotic inpatients (1995) (0)
- Characterizing traumatic brain injury and its association with homelessness in a community-based sample of precariously housed adults and youth (2019) (0)
- Title Maintenance treatment with quetiapine versus discontinuation after one year of treatment in patients with remitted first episode psychosis : Randomised controlled trial (2010) (0)
- Somatostatin cell densities in the striatum in schizophrenic patients and control subjects (1998) (0)
- Research methods in schizophrenia (2009) (0)
- ASSESSING THE UTILITY OF PHARMACOGENETIC TESTING IN A COHORT WITH TREATMENT-RESISTANT SCHIZOPHRENIA OR SCHIZOAFFECTIVE DISORDER (2022) (0)
- Changes in the incidence of schizophrenia in British Columbia: 1907 to 1913 (2003) (0)
- Effects of risperidone and typical antipsychotics on basal ganglia volumes in patients with schizophrenia (2000) (0)
- SU48. A Comparison of Psychotic Symptoms in Subjects With Cocaine or Methamphetamine Dependence vs Schizophrenia Spectrum Disorder (2017) (0)
- 14:30 EFFECTS OF EIGHT WEEKS OF ATYPICAL ANTI-PSYCHOTIC MEDICATION TREATMENT ON MIDDLE FRONTAL THICKNESS IN DRUG-NAÏVE FIRST EPISODE PSYCHOSIS PATIENTS (2012) (0)
- P.3.a.008 Reduced SNAP-25 fragmentation in orbitofrontal cortex may underlie synaptic dysfunction associated with schizophrenia (2016) (0)
- Reviewer List (2019) (0)
- Differential age-associated brain atrophy and white matter changes among homeless and precariously housed individuals compared with the general population (2021) (0)
- 65. Cingulate cortex presynaptic proteins in schizophrenia (1996) (0)
- PANSS symptom factors in schizophrenia and non-schizophrenic psychoses (2000) (0)
- Psychometric properties and correlates of the Beck Depression Inventory in a community-based and homeless or precariously housed sample (2021) (0)
- Atypical antipsychotic medications and memory enhancement in schizophrenia (2003) (0)
- F181. CHANGE IN PREFRONTAL-LIMBIC MORPHOLOGY AND COGNITION IN DRUG-NAïVE FIRST-EPISODE PSYCHOSIS PATIENTS FOLLOWING ATYPICAL ANTIPSYCHOTIC TREATMENT: A BRIEF LONGITUDINAL STUDY (2018) (0)
- NOVEL TREATMENT OPTIONS FOR IMPAIRED COGNITION IN SCHIZOPHRENIA: COMBINING DIFFERENT MODES OF COGNITIVE REMEDIATION (2014) (0)
- amphetamine-increased 4-hydroxynonenal-protein adducts in rat frontal cortex (2011) (0)
- Influence of positive and negative symptoms and thought disorder on mini-mental state examination scores (1993) (0)
- Clozapine and COVID-19: The authors respond. (2020) (0)
- 256 – Heterozygous reeler mice exhibit alterations in sensorimotor gating, but not presynaptic proteins (2008) (0)
- Impact of cannabis mass gathering events on mental health and health service utilization (2020) (0)
- SU60. Risk and Protective Factors Associated With Psychotic Symptom Profiles of Marginally Housed Adults (2017) (0)
- Obstetric complications in chronic schizophrenia (1993) (0)
- In vivo visualization of corpus callosum abnormalities in schizophrenia (2003) (0)
- Brain IGFBP-5 Modifies the Relation of Depressive Symptoms to Decline in Working Memory in Older Persons (2019) (0)
- Hippocampal volume in sporadic schizophrenics, multiple affected families with schizophrenia and normal controls. a morphometric MRI study (1998) (0)
- Relapse prevention in first-episode psychosis patients with stable maintenance medication for at least one year (2009) (0)
- ssociation Between Schizophrenia and the Syntaxin A Gene lbert (2004) (0)
- Clozapine Optimization: A Delphi Consensus Guideline From the Treatment Response and Resistance in Psychosis Working Group. (2023) (0)
- P.3.c.006 Inhibitors of SNARE assembly as potential drugs for schizophrenia treatment: a screening study (2013) (0)
- 279 Subgroups of patients with unilateral olfactory identification deficits in schizophrenia: Different etiological profiles? (1997) (0)
- P.3.d.005 Treatment of acute olanzapine-induced glucose dysregulation in rats: oral administration of metformin, rosiglitazone and glyburide (2011) (0)
- 286 – Syntaxin isoform expression in the striatum in schizophrenia (2008) (0)
- Better Evidence for Pharmacological Maintenance Treatment in Nonaffective Psychoses: Implications for Relapse Prevention. (2021) (0)
- A Longitudinal Characterization of Cerebral Microbleeds in a Marginalized Population with High Rates of Mental Illness, Substance Abuse and Viral Infection (P3.390) (2016) (0)
- Search for unstable DNA in schizophrenia families demonstrating evidence for genetic anticipation (1995) (0)
- Editorial on the Special Issue on SNARE Proteins: A Long Journey of Science in Brain Health and Disease (2019) (0)
- Accelerated Brain Atrophy and Changes in White Matter Diffusivity are Associated With Mortality, Declining Health, and Declining Cognitive Functioning Among Homeless and Precariously Housed Individuals: A Longitudinal Study (2022) (0)
- 233 – The effects of physical exercise on brain morphology in patients with schizophrenia (2008) (0)
- BRAIN CHOLESTEROL IN PREFRONTAL GREY AND WHITE MATTER IN SCHIZOHRENIA AND BIPOLAR DISORDER: ASSOCIATION WITH ApoE GENOTYPE (2008) (0)
- A comparison of psychotic symptoms in subjects with methamphetamine versus cocaine dependence (2017) (0)
- Working memory deterioration as an early warning sign for relapse in remitted psychosis: A one-year naturalistic follow-up study (2022) (0)
- The temporal lobe in families with schizophrenia: Effects of diagnosis and family of origin (1995) (0)
- The cytoarchitecture of the superior temporal gyrus in bipolar disorder using GLI-methodology (2002) (0)
- S.19.03 Influence of exercise in combination with clozapine and other antipsychotics in chronic refractory schizophrenia patients (2017) (0)
- M216. ASSOCIATIONS OF EXTRAPYRAMIDAL SYMPTOMS WITH PSYCHOTIC SYMPTOMS IN A COHORT OF HOMELESS OR PRECARIOUSLY HOUSED PERSONS WITH OR WITHOUT SCHIZOPHRENIA (2020) (0)
- SOCIAL NETWORK CHARACTERISTICS AND EFFECT ON SEVERITY OF PSYCHOSIS IN A COMMUNITY SAMPLE WITH HIGH PREVALENCE OF STIMULANT USE (2010) (0)
- PILOT STUDY OF THE PERCEPTIONS OF GENETIC RISK ESTIMATION AND ASSOCIATED REPRODUCTIVE DECISIONS IN CHINESE (2009) (0)
- New Perspectives on the Clinical Neurobiology of Treatment Response in Schizophrenia (1994) (0)
- Effects of the SORL1 Alzheimer's disease risk gene across the human lifespan (2013) (0)
- Authors' response to commentaries (1995) (0)
- Structural brain imaging in partial trisomy chromosome 5 with schizophrenia (1991) (0)
- A 20-year population-based study of all-cause and cause-specific mortality among people with concurrent HIV and psychotic disorders (2022) (0)
- P 0091 Sex differences in the outcome of first episode psychosis (0)
- S0033291720004444jra 2559..2569 (2022) (0)
- A comparison of regional brain volumes and white matter connectivity in subjects with stimulant induced psychosis versus schizophrenia (2019) (0)
- EVALUATION OF THE PRESYNAPTIC PROTEIN SNAP-25 AS A NOVEL CEREBROSPINAL FLUID MARKER FOR SYNAPTIC PATHOLOGY IN ALZHEIMER'S DISEASE (2014) (0)
- From antibody to gene in schizophrenia: Methodology and progress report (1991) (0)
- Synaptic proteins in schizophrenia: a “bottom-up” approach to neural connectivity (2002) (0)
- Error in Results Sections. (2019) (0)
- Loss of synaptic proteins and choline acetyltransferase in primary and secondary visual cortex in dementia with Lewy bodies (2008) (0)
- Velocardiofacial syndrome (VCFS) in a random schizophrenic sample (1996) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With William G. Honer?
William G. Honer is affiliated with the following schools:
